Paliperidone Palmitate Every Three Months (PP3M) 2-Year Treatment Compliance, Effectiveness and Satisfaction Compared with Paliperidone Palmitate-Monthly (PP1M) in People with Severe Schizophrenia

Paliperidone Palmitate Every Three Months (PP3M) 2-Year Treatment Compliance, Effectiveness and Satisfaction Compared with Paliperidone Palmitate-Monthly (PP1M) in People with Severe Schizophrenia

Paliperidone palmitate every three months (PP3M) is expected to facilitate patient’s treatment compliance and satisfaction. The objective here was to compare PP3M treatment compliance and satisfaction, effectiveness and tolerability, with paliperidone palmitate-monthly (PP1M) in patients with severe...

Full description

Bibliographic Details
Main Authors: Juan J. Fernández-Miranda, Silvia Díaz-Fernández, Domenico De Berardis, Francisco López-Muñoz
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Journal of Clinical Medicine
Subjects:
schizophrenia
antipsychotic
treatment effectiveness
treatment satisfaction
treatment compliance
long-acting injectable
Online Access:https://www.mdpi.com/2077-0383/10/7/1408

Internet

https://www.mdpi.com/2077-0383/10/7/1408

Similar Items